During the development of the adult central nervous system (CNS) of the fruit¯y Drosophila melanogaster, the A-isoform of the ecdysone receptor (EcR-A), a typical nuclear hormone receptor, is expressed at high levels in the Type II neurons, a set of neurons that die shortly after the emergence of the adult. To understand the role that transcriptional regulation of nuclear receptor genes plays in CNS development, we have dissected the region controlling the transcription of EcR-A by analyzing the ability of this region to drive the expression of reporter genes in transgenic animals. These analyses have demonstrated that the Type II neurons are a heterogeneous collection of neurons that utilize different regulatory elements to coordinate the expression of the same transcript. q
Introduction
Steroid hormones, thyroid hormones, and retinoids play important roles in the development of the nervous system regulating diverse processes such as neurogenesis, the maturation of immature neurons, the re-speci®cation of pre-existing neurons, and the programmed death of others (reviewed in Calza et al., 1997; Clagett-Dame and Plum, 1997; Flanagan-Cato and Fluharty, 1997; Spindler, 1997; Cooke et al., 1998; Denver, 1998; Durston et al., 1998; Maden, 1998) . This diversity of cellular responses is not an inherent property of the hormonal signal but instead is due to the ability of individual cells to respond differentially to the same hormonal cue. A major route of action of these hormones is to alter gene expression in target cells through an interaction with a class of receptors, termed nuclear hormone receptors, that are hormone-regulated transcription factors (Mangelsdorf et al., 1995) . Thus the ability of neurons to respond differentially to the same hormonal cue is, to a ®rst approximation, due to qualitative and quantitative differences in the expression of these hormone-regulated transcription factors. To fully understand why similar cells within a developing nervous system respond differently to the same hormonal exposure, one must not only characterize the temporal and spatial patterns of expression of nuclear hormone receptors, but ultimately one must elucidate the mechanisms that generate these patterns in the ®rst place.
Differences in receptor expression are generally ®rst observed as differences in the temporal and spatial distribution of mRNAs transcribed from the genes encoding these receptors (reviewed in Denver, 1998; Durston et al., 1998; Keightley, 1998) . That nuclear hormone receptors display unique and characteristic patterns of expression at the level of mRNA suggests that gene transcription plays a major role, although possibly not the only role (Morimoto et al., 1996) , in regulating the expression of nuclear hormone receptor genes. If this is the case, then to elucidate the molecular basis for the differential expression of nuclear hormone receptors one must decipher the interactions between transcription factors and the regulatory elements of nuclear hormone receptor genes.
We have been studying the development and hormonal regulation of neurons that express high levels of the Aisoform of the ecdysone receptor (EcR-A) (Robinow et al., 1993 (Robinow et al., , 1997 , a typical nuclear hormone receptor of the fruity Drosophila melanogaster . The expression of this transcription unit is highly regulated in the nervous system during metamorphosis, a period when the nervous system undergoes a dramatic reorganization (Truman et al., 1994) . Most neurons express low levels of EcR-A during metamorphosis and in the adult. However during the early stages of metamorphosis approximately 300 neurons, termed Type II, up-regulate the expression of EcR-A and maintain high levels throughout metamorphosis and into the adult. Shortly after emergence of the adult (eclosion), 100% of the Type II neurons undergo programmed cell death and die by apoptosis (Robinow et al., 1993) . The death of these neurons requires the withdrawal of ecdysteroids (Robinow et al., 1993) . Twelve of these 300 Type II neurons, designated n1, n2, n3, n4, and n5, are readily identi®able based on the expression of high levels of EcR-A protein and their unique position in the ventral nervous system (Robinow et al., 1993) . Of these twelve Type II neurons, all are recognized as pairs except the quartet of n4 neurons. The four n4 neurons are likely to represent two distinct pairs (Robinow et al., 1997) , but these pairs cannot be distinguished based on their position within the ventral nervous system.
In addition to the doomed Type II neurons and the majority of neurons that survive and express low levels of EcR-A, four additional identi®able neurons, the n6 and n7 pairs, regulate EcR-A expression in a unique temporal manner. While the n6/n7 neurons express high levels of EcR-A protein in the newly eclosed adult as do the Type II neurons, the n6 and n7 neurons do not die. Developmentally, the n6 neurons up-regulate EcR-A at the outset of metamorphosis only to down-regulate expression during mid-metamorphosis. Approximately 24 h before eclosion EcR-A is again upregulated in these neurons. Expression of EcR-A remains high in the n6 neurons for the remainder of the life of the¯y. In contrast, the n7 neurons up-regulate EcR-A only once, ,24 h prior to eclosion in concert with the n6 neurons. Curiously, the n7 neurons express high levels of EcR-A brie¯y. These neurons down-regulate EcR-A 24-48 h posteclosion but do not die (Robinow et al., 1993) .
The differences in temporal patterns of expression between the Type II neurons and the n6/n7 neurons may be due to the utilization of different cis-acting EcR-A regulatory sequences, or may be due to the temporal modulation of transcription factors acting on the same cis-regulatory sequences in the different cell types. In this paper we describe studies testing the transcriptional regulatory properties of elements upstream of the EcR-A transcription unit. The data show that EcR-A expression in the Type II neurons and in the n6/n7 neurons is regulated by distinct cis-acting sequences. The data also demonstrate that regulation of EcR-A in the Type II neurons requires unique cis-acting sequences for discrete subsets of the Type II neurons. Therefore, the Type II neurons themselves must be a heterogeneous collection that utilizes different regulatory elements to coordinate the temporal expression of this transcript.
Results

Expression of EcR-A is transcriptionally regulated
When neurons express high levels of EcR-A protein, whether doomed or not, they also express high levels of EcR-A speci®c RNA (Fig. 1) . These data suggest that the level of protein expressed is a direct re¯ection of the rate of transcription from the EcR-A promoter. Thus to study the expression of this gene, it is appropriate to concentrate on genomic sequences that regulate transcription from the EcR-A promoter.
Mapping the regulatory elements of the EcR-A transcription unit
To identify and characterize regulatory elements of the EcR-A transcription unit, various restriction fragments spanning a 13.75 kb genomic interval upstream of the transcription initiation site of EcR-A were tested for the ability to activate transcription of a LacZ reporter gene in neurons n1±n7. This upstream region was divided into eight intervals, A through H, based on the position of useful restriction enzyme sites ( Fig. 2A) . Interval A was the most distal interval tested relative to the promoter, and interval H was the Fig. 1 . High levels of EcR-A mRNA were observed in neurons that express high levels of EcR-A protein. Nervous systems from newly eclosed animals (0±2 h) were processed to detect EcR-A speci®c mRNA using whole-mount in situ hybridization techniques. Cells expressing high levels of EcR-A speci®c mRNA were observed in positions characteristic of identi®ed neurons that express high levels of EcR-A protein (Robinow et al., 1993) . Nine neurons are shown that express high levels of EcR-A mRNA. The identity of these neurons is inferred based upon our knowledge of the position of identi®ed neurons that express high levels of EcR-A protein. Scale bar represents 50 mm.
interval most proximal to the promoter. Restriction fragments spanning two or more intervals were cloned into one of three enhancer tester vectors (Fig. 2B) . Vector ET was derived from the AUG-b-gal vector (Thummel et al., 1988) in which the EcR-A promoter and transcription start site were placed upstream of the reporter gene LacZ. The C4PLZ vector (PLZ series, Fig. 2B ) contains a LacZ reporter gene that is transcribed from a P-element promoter (Wharton and Crews, 1993) . The GET vector was assembled in the CaSpeR4 vector (Thummel and Pirrotta, 1992) and places the EcR-A promoter and transcription start site upstream of the GAL4 open reading frame (Brand and Perrimon, 1993; Brand et al., 1994) . All constructs were introduced into¯ies by P-element mediated germline transformation (Rubin and Spradling, 1982) . Multiple independent lines of each construct were characterized.
2.3. The ET series of enhancer tester constructs 2.3.1. Interval AG activates expression of b -galactosidase from the reporter gene LacZ in neurons n1±n7
Initially, two overlapping intervals (AG and GH) spanning the entire 13.75 kb region were tested for the ability to activate transcription of the LacZ gene in neurons n1±n7. To determine whether construct ET-AG or construct ET-GH were able to activate transcription of the reporter gene in neurons n1±n7, ventral nervous systems of transgenic¯ies carrying these constructs were dissected 0±2 h after eclosion, and processed using standard immunohistochemical procedures to detect simultaneously EcR-A and b-galactosidase. These samples were analyzed by confocal microscopy. Neurons n1±n7, that expressed high levels of EcR-A, were inspected to determine whether these same neurons also displayed b-galactosidase-immunoreactivity (IRy). bgalactosidase-IRy was not detected in neurons n1±n7 in transgenic lines carrying the basic ET vector (Fig. 3) . In ET-GH lines, b-galactosidase-IRy was detected only very weakly in the n7 neurons, if at all, and not at all in neurons n1-n6 (Fig. 3) . However, b-galactosidase-IRy was readily detected in all neurons n1±n7 of ET-AG lines (Fig. 3 ). These observations demonstrate that interval AG contains elements able to activate the expression of the LacZ gene in neurons n1±n7. Since interval AG activates reporter gene expression in neurons n1±n7 and interval GH does not, it is likely that the regulatory elements of interest are localized in the interval AF.
To determine whether interval AG was able to control bgalactosidase expression in the appropriate temporal manner, nervous systems of aged ET-AG pupae were processed to detect simultaneously EcR-A and b-galactosidase. We examined the n4 neurons every four hours for a 24 h period beginning 12 h after head eversion. During this interval the n4 neurons up-regulate EcR-A. The n6 and n7 neurons were not examined because the coordinated upregulation of EcR-A in these neurons does not occur until approximately 68 h after head eversion (Robinow et al., 1993) . The n4 neurons were ®rst readily and reliably detected 20 h after head eversion (Fig. 4) at which time the n4 neurons expressed high levels of EcR-A, but b-galac- (Brand and Perrimon, 1993; Brand et al., 1994) . The PLZ vector series tested the ability of regulatory regions to activate transcription from a heterologous Pelement promoter to drive expression of a LacZ reporter gene. tosidase was not detectable (Fig. 4a,e) . b-galactosidase was ®rst detected in the n4 neurons 24 h after head eversion and continued to accumulate in the n4 neurons at later times ( Fig. 4b±h ) demonstrating that the onset of b-galactosidase expression lags behind the onset of EcR-A expression in the n4 neurons by approximately 4 h. The onset of expression of both EcR-A and b-galactosidase was not always uniform ( Fig. 4c,g ). However, the delayed up-regulation of EcR-A (Fig. 4c ) was re¯ected in a delayed up-regulation of bgalactosidase ( Fig. 4g) suggesting that the occasional lack of uniformity during the onset of expression is a property associated with EcR-A regulatory elements. At eclosion, high levels of EcR-A and b-galactosidase are reliably detected in all four n4 neurons (Fig. 3) .
The PLZ series of enhancer tester constructs
To con®rm the results of the ET series, we tested the regulatory properties of the interval AG in the enhancer tester vector C4PLZ that uses a P-element promoter to transcribe the LacZ gene. The PLZ-AG construct contains the same fragment, interval AG, as in construct ET-AG. bgalactosidase-IRy was readily detected in neurons n1±n7 in recently eclosed adults of transgenic animals carrying the PLZ-AG construct (Fig. 5 ), similar to results observed for the ET-AG construct, demonstrating that interval AG can regulate expression using a heterologous promoter.
To further localize the elements controlling spatial expression in neurons n1±n7 within the interval AG, three overlapping fragments of interval AG were cloned into the C4PLZ vector generating constructs PLZ-DG, PLZ-BD, and PLZ-AB. Transgenic¯ies carrying these constructs were tested to determine the regulatory properties of each genomic region by comparing the pattern of expression of b-galactosidase in lines carrying these constructs to that of PLZ-AG which contains the entire interval (Fig. 5 ).
Of these various constructs, b-galactosidase-IRy was readily detected in all identi®ed neurons (n1±n7) only in PLZ-AG lines. In PLZ-DG lines, b-galactosidase-IRy was comparable to expression in PLZ-AG lines in neurons n2, n4, n6, and n7. b-galactosidase-IRy in the n5 neurons of PLZ-DG lines was noticeably weaker than in PLZ-AG lines, although strong b-galactosidase-IRy was observed in a cell neighboring n5. Additionally, b-galactosidaseIRy was not detected in the n1 and n3 neurons of PLZ-DG lines (Fig. 5) . Lines carrying the PLZ-BD construct Fig. 3 . Interval AG regulates reporter gene expression in the ET vector in a manner similar to the endogenous EcR-A transcription unit. Ventral nervous systems were dissected from animals within 2 h of eclosion. Tissues were processed to detect both EcR-A-IRy and b-galactosidaseIRy and analyzed on a BioRad MRC 1024 confocal microscope. Only bgalactosidase-IRy is shown in these ®gures. Arrows indicate the neurons n1±n7 that expressed high levels of EcR-A. Empty circles identify the neurons n1±n7 in which b-galactosidase was not detectable. Arrowheads identify cells that expressed low levels of EcR-A and high levels of bgalactosidase. ET: b-galactosidase-IRy was not detected at a signi®cant level in any of the identi®ed neurons n1±n7 in lines carrying the basic ET vector. ET-GH: b-galactosidase-IRy was not detected at a signi®cant level in any of the identi®ed neurons n1±n7 ET-GH lines. Very weak bgalactosidase expression was sometimes detected in the n7 neurons. ET-AG: In ET-AG lines, b-galactosidase-IRy was detected at high levels in all identi®ed neurons n1±n7. Of the ®ve b -galactosidase-immunoreactive neurons in the ET-AG n4 panel, four are n4 neurons (white arrows) and the ®fth is an n6 neuron (gray arrow). Based on the stereotactic position within the vns, we can distinguish the n4 neurons from the n6 neurons. The faint b-galactosidase-immunoreactive neuron (arrowhead) in panel n5 is motorneuron MN5 (Ikeda and Koenig, 1988) . The identity of the EcR-Anegative, b-galactosidase-immunoreactive cells in panels n6 and n7 have not been determined (arrowhead). Scale bar represents 10 mm.
displayed robust levels of b-galactosidase-IRy in neurons n1, n3, n5, n6, and n7. b-galactosidase-IRy was weak in the n2 neurons and barely detectable in the n4 neurons (Fig. 5) . In lines carrying construct PLZ-AB, made from the most distal genomic fragment tested, b-galactosidase-IRy was comparable to expression in PLZ-AG lines in neurons n1, n2, n3, and n5. b-galactosidase-IRy was not detected in the n6 neurons, and detected at levels just above background in the n7 neurons. b-galactosidase expression in the n4 neurons was heterogeneous, being detected at moderate levels in two of the n4 neurons, and barely detectable in the other two n4 neurons (Fig. 5) .
The GET enhancer tester constructs
The GET enhancer tester vector utilizes the EcR-A promoter to initiate transcription of the yeast transcriptional activator GAL4. Three constructs were made in the GET vector; GET-AG, GET-BD, and GET-CE. We predicted that GET-AG would activate GAL4 expression in neurons n1±n7, identical to the reporter gene expression observed in ET-AG and PLZ-AG lines. Based on the reporter gene expression observed in PLZ-BD lines, we anticipated that GET-BD would activate robust levels of GAL4 expression in neurons n1, n3, n5, n6, and n7, low levels in the n2 neurons, and barely detectable levels in some but possibly not all of the n4 neurons. Based on an analysis of lines PLZ-DG, PLZ-BD and PLZ-AB, an element that controls expression in the n1 and n3 neurons was expected to be found in interval B, but not in interval CG. Therefore, we predicted that GET-CE would not drive reporter gene expression in either the n1 neurons or the n3 neurons. Similarly, the observations that PLZ-DG and PLZ-BD lines mediated robust levels of b-galactosidase expression in neurons n6 and n7, but that PLZ-AB did not, suggested that interval D might contain regulatory elements to drive high level expression in the n6 and n7 neurons. Therefore we predicted that GET-CE, which contains interval D, would drive high-level reporter gene expression in the n6 and n7 neurons. Predictions concerning the ability of GET-CE to drive high-level reporter gene expression in neurons n2, n4, and n5 could not be made based on the available data.
To visualize reporter gene expression, GET lines were crossed to a line carrying a UAS-LacZ transgene. Thus, bgalactosidase was expressed in GAL4 expressing cells (Brand et al., 1994; Brand and Perrimon, 1993) . b-galactosidase expression was visualized using standard immunohistochemical techniques.
Consistent with the properties of the genomic interval AG, GET-AG lines expressed b-galactosidase in neurons n1±n7, similar to results of lines carrying ET-AG and PLZ-AG (Figs. 3, 5 and 6) . Consistent with the properties of PLZ-BD, in GET-BD lines b-galactosidase-IRy was readily detected in neurons n1, n3, n5, and n7, not detected in the n2 neurons, and was detected at low levels in only two of the four n4 neurons (Fig. 6) . Curiously, b-galactosidase- Fig. 4 . The onset of b-galactosidase expression in the n4 neurons. Ventral nervous systems of ET-AG animals were dissected at various times after head eversion. Tissues were processed to detect both EcR-A and b-galactosidase. The n4 neurons, identi®ed by position and EcR-A-IRy (a±d), were inspected using a BioRad MRC 1024 confocal microscope to determine whether they also expressed b-galactosidase (e±h). Arrowheads identify n4 neurons in which bgalactosidase was not detected. Arrows identify n4 neurons in which b-galactosidase was detected. (a,e) Twenty hours after head eversion, the n4 neurons did not express any detectable b-galactosidase (arrowheads). (b,f) Twenty-four hours after head eversion, three n4 neurons expressed low levels of b-galactosidase (white arrows). The fourth n4 neuron expressed levels of b-galactosidase that were barely detectable (gray arrow). (c,g) Twenty-eight hours after head eversion, b-galactosidase was readily detected in three n4 neurons (arrows). The fourth n4 neuron expressed noticeably lower levels of EcR-A (arrowhead). bgalactosidase was not detected in this fourth n4 neuron (arrowhead). (d,h) Thirty-two hours after head eversion, b-galactosidase was detected in all n4 neurons (arrows). Scale bar represents 10 mm.
IRy was detected in the n6 neurons of GET-BD lines, but not at the robust levels that had been observed in PLZ-BD (Figs. 5 and 6 ).
In GET-CE lines, high level expression of the reporter gene was detected only in the n2 neurons and the n4 neurons (Fig. 6) . It is interesting to note that all four n4 neurons Fig. 5 . EcR-A regulatory elements can drive expression from a heterologous promoter: the PLZ Series. Ventral nervous systems were dissected and processed as described in the legend for Fig. 3 . PLZ-AG: In PLZ-AG lines, b-galactosidase-IRy was detected in neurons n1±n7. The level of b-galactosidase expression was highest in neurons n1 and n5. The level of b-galactosidase expression observed in the n3, n4, and n7 neurons was distinctly lower than that observed in neurons n1 and n5. The staining in this line was the most robust of the six independent PLZ-AG lines that were tested. PLZ-DG: b-galactosidase-IRy was detected at high levels in the n2, n6 and n7 neurons in PLZ-DG lines. Low level b-galactosidase expression was detected in all n4 neurons and in the n5 neurons. b-galactosidase was not detected in neurons n1 and n3 (circles). Ectopic b-galactosidase expression was detected in a neuron adjacent to n5. The identity of this neuron has not been determined. PLZ-BD: In PLZ-BD lines, b-galactosidase was expressed at very high levels in neurons n1, n3, n5, n6, and n7. Very weak b-galactosidase expression was detected in n2 and three of the four n4 neurons. b-galactosidase-IRy was undetectable in the fourth n4 neuron (circle). Moderate b-galactosidase levels were detected in MN5 (arrowhead; right edge of panel n5) and high levels were detected in a cell adjacent to n5 (arrowhead; panel n5). PLZ-AB: In PLZ-AB lines b-galactosidase was detected at high levels in neurons n1 and at moderate levels in neurons n2, n3, and n5. b-galactosidase was detected in two of the n4 neurons at moderate levels and detected at levels barely above background in the other two n4 neurons. bgalactosidase was also detected at extremely low levels in the n7 neurons and not at all in the n6 neurons (circles). Scale bar represents 10 mm.
expressed b-galactosidase in GET-CE lines, but that one pair always expressed higher levels than the other pair supporting the hypothesis that the n4 neurons actually represent two distinct pairs of neurons (Robinow et al., 1997) . Moderate levels of b-galactosidase were detected in the n5 neurons. Consistent with our predictions, b-galactosidase was not detected in neurons n1 and n3. However, contrary to our predictions, b-galactosidase was also not detected in neurons n6 and n7 (Fig. 6 ).
Ectopic reporter gene expression in a set of¯ight motorneurons
In GET-AG and GET-BD lines, b-galactosidase-IRy was detected at high levels in large neurons located near n5 (GET-AG, Fig. 6 ; GET-BD, not shown) and n7 (Figs. 6 and 7). These neurons were easily visualized 24 h after eclosion when all Type II neurons had died, thus simplifying the expression pattern of both EcR-A and b-galactosidase. Of the b-galactosidase-immunoreactive neurons observed at this time, only the n7 neurons expressed high levels of EcR-A (Robinow et al., 1993 ; data not shown). The b-galactosidase expressing cell near n5 was tentatively identi®ed as MN5 because of its unusually large size and characteristic position in the dorsal-most portion of the ventral nervous system (Fig. 7) (Ikeda and Koenig, 1988) . MN5 innervates the dorsal longitudinal indirect¯ight muscles (DLM) 5 and 6 (Ikeda and Koenig, 1988) . The b-galactosidase-immunoreactive cells in the vicinity of n7 were in the appropriate position to include MN1, MN2, MN3, and MN4; motorneurons that innervate dorsal longitudinal¯ight muscles 1, 2, 3, and 4, respectively, (Ikeda and Koenig, 1988) . The medial position of n7 suggested that it was not one of these motorneurons.
To test whether the b-galactosidase-immunoreactive cells near n7 included motorneurons MN1-4 and to con®rm the identity of MN5, we used a GET-AG line to drive the expression of the membrane-targeted chimeric protein mCD8-GFP (Lee and Luo, 1999) . If GET-AG drives expression in motorneurons MN1-4 and MN5, then the mCD8-GFP transmembrane protein should be detected in the axons that innervate the dorsal longitudinal¯ight muscles. 72 h after eclosion, thoraces of GET-AG; UAS-mCD8-GFP ies were split along the midline and processed to detect the CD8 antigen (Lee and Luo, 1999) . A CD8-immunoreactive process was observed exiting the ventral nervous system (data not shown) and branching along all six dorsal longitudinal muscles (Fig. 8) demonstrating that the GET-AG transgene must drive expression in motorneurons MN1-4 and MN5. In these preparations it was also possible to view the dorsal ventral indirect¯ight muscles (DVM). In some samples, DVMs were innervated by CD8-immunoreactive axons. Thus, even though the motorneurons innervating all Fig. 6 . The EcR-A regulatory region drives expression of GAL4 in the GET constructs. GET-AG: In GET-AG lines b-galactosidase-IRy was detected at high levels in neurons n1±n7. Ectopic expression was detected in MN5 (arrowhead, panel n5) and in other cells that expressed low levels of EcR-A (arrowheads; panel n7). GET-BD: In GET-BD lines, high levels of bgalactosidase were detected in neurons n1, n3, n5, and n7. b-galactosidase was detected at low levels in two of the n4 neurons, and in the n6 neurons. b-galactosidase was not detected in the n2 neurons or in two of the n4 neurons. Ectopic expression was observed in two cells surrounding the n2 neuron (arrowheads), in cells near n7 (arrowheads), and in MN5 (not shown). GET-CE: In GET-CE lines b-galactosidase-IRy was detected at high levels only in the n2 and n4 neurons. As in the GET-BD construct, two n4 neurons expressed the reporter gene at higher levels than the other two n4 neurons. b-galactosidase-IRy was detected at low levels in the n5 neurons and not detected at all in neurons n1, n3, n6, and n7. Additionally, ectopic expression of b-galactosidase was not detected in any cells near n7. Scale bar represents 10 microns. indirect¯ight muscles normally expressed low levels of EcR-A, the GET-AG transgene was able to drive reporter gene expression in the DLM motorneurons MN1-5, and possibly in the DVM motorneurons as well.
Discussion
We have investigated the regulatory properties of a 13.75 kb genomic region located immediately upstream of the EcR-A transcription unit. Fig. 9 summarizes the results of the ability of this region (interval AH) to drive high level reporter gene expression in neurons n1±n7 in the ventral nervous system of newly eclosed¯ies. The combined effects of interval AG resulted in high level expression of the reporter gene in all neurons n1±n7 as demonstrated by constructs ET-AG, PLZ-AG and GET-AG. Analysis of lines carrying the constructs ET-GH, PLZ-DG, PLZ-BD, PLZ-AB, GET-BD, and GET-CE have allowed us to infer the position of regulatory elements that confer robust reporter gene expression in speci®c sets of these neurons. Regulatory elements for neurons n1 and n3 map to interval B. Elements for the n2 neurons map to both intervals A and E. Interval E also appears to contain elements specifying expression in all four n4 neurons. Regulatory elements specifying expression in the n5 neurons could not be mapped to any individual interval. However there must be at least two such elements and they are not located in interval GH. Regulatory elements for neurons n6 and n7 map to the same two positions. One n6/n7 element maps to interval F. Mapping of the second n6/n7 element is based on the observations that intervals AB and CE do not drive expression in n6 or n7, yet interval BD does drive reporter gene expression in neurons n6 and n7 (Fig. 9B) . These results are contradictory Fig. 7 . GET-AG drives reporter gene expression in neurons that express low levels of EcR-A. Ventral nervous systems were removed from GET-AG; UASLacZ¯ies 24 h after eclosion. All Type II neurons had died by this time and the only neurons that expressed high levels of EcR-A were the n6 and n7 neurons. (a) Tissues were processed to visualize b-galactosidase using an immunoperoxidase detection method. (b±d) Tissues were processed immunohistochemically to detect both EcR-A and b-galactosidase, and analyzed on a BioRad MRC 1024 confocal microscope. While only b-galactosidase-IRy is shown, EcR-A-IRy allowed identi®cation of the n7 neuron; the only cell in the ®eld that expressed high levels of EcR-A. (a) A composite photomicrograph showing cells that expressed b-galactosidase 24 h after eclosion. The n6 neurons were readily identi®ed based on their position along the midline. The n7 neurons could not be identi®ed because they were among a cluster of b-galactosidase-immunoreactive neurons lateral to the n6 neurons. MN5 was identi®ed based on its size and position (Ikeda and Koenig, 1988) as well as on the data shown in if the proposed n6/n7 element is located within an interval. However, these results are consistent with a model in which an n6/n7 regulatory element spans the B/C border.
Interval AG confers not only the correct spatial expression, but this interval also confers the correct temporal expression based on the observation that onset of EcR-A expression precedes the onset of reporter gene expression (b-galactosidase) by as little as 4 h. The nature of this lag is unknown but may re¯ect constraints imposed by the chromosomal position of the transgene or delays in post-transcriptional events, and may be independent of the regulatory properties of interval AG. Thus, we propose that interval AG contains the essential elements required to drive the correct temporal expression of EcR-A in the n4 neurons and in all Type II neurons.
In addition to mapping elements of the EcR-A transcription unit that regulate gene expression in neurons n1±n7, we have also mapped an element to interval B that activates high level expression of b-galactosidase in the motorneurons that innervate the dorsal longitudinal¯ight muscles, MN1-5 (Fig. 9) . This element was mapped to interval B based on the observations that intervals AG and BD drive reporter gene expression in MN1-5, but that interval CE does not (Fig. 9B) . The identi®cation of this regulatory element was surprising because these motorneurons expressed low levels of EcR-A. To reconcile these seemingly contradictory results, we propose that in addition to positive regulatory elements, there also exist negative regulatory elements that suppress EcR-A transcription in these¯ight motorneurons and that these various elements modulate the expression of EcR-A in these motorneurons. Such a negative regulatory element might reside in interval H or upstream of interval A. Further experimentation is necessary to thoroughly characterize the positive regulatory Fig. 8 . The GET-AG transgene drives reporter gene expression in motorneurons MN1-5. Thoraces of GET-AG; UAS-mCD8-GFP adults were split down the midline and processed to detect the mCD8-GFP transmembrane reporter gene. CD8-immunoreactive axons (thick lines) and muscles (thin lines) were traced from a video monitor. Axons innervating all six dorsal longitudinal¯ight muscles expressed the CD8 epitope. The numbers 1±6 identify each dorsal longitudinal¯ight muscle (Ikeda and Koenig, 1988) . Scale bar represents 10 mm. Fig. 9 . Summary of enhancer tester constructs. Results of the ability of EcR-A regulatory regions in one or more of the three enhancer tester constructs to drive high-level reporter gene expression. (A) map of the region upstream of the EcR-A transcription unit as shown in Fig. 2 . These fragments were tested for the ability to drive reporter gene expression in identi®ed neurons. (B) A tabulation of the ability of the genomic fragments shown in (A) to drive high level reporter gene expression in speci®ed neurons. The fragment spanning interval GH was unable to drive reporter gene expression in any of the neurons studied. The fragment spanning interval AG was able to drive high-level expression in all neurons studied. Interval DG was able to drive high-level reporter gene expression in neurons n2, n4, n5, n6, and n7 but not in neurons n1, or n3. Interval CE was able to drive high-level reporter gene expression only in neurons n2, n4, and n5, but not in any other neurons investigated. Interval BD was able to drive high-level reporter gene expression in neurons n1, n3, n5, n6, and n7. Interval AB was able to drive high-level reporter gene expression in neurons n1, n2, n3, and n5, but not in n4, n6, or n7. Ectopic reporter gene expression in MN5 and in a cluster of cells that included motorneurons MN1-4 (dark gray box) was observed in ET-AG lines, GET-AG lines, and GET-BD lines, but not in GET-CE lines. A negative sign (2) indicates that a particular fragment was never observed to drive high-level expression in the identi®ed neurons. A plus sign (1) indicates that this genomic fragment was able to drive high-level reporter gene expression in these neurons from multiple independent lines of at least one enhancer tester vector. nt, not tested. The gray boxes highlight non-Type II neurons, neurons that survive in the adult. element and to assay for the presence of this proposed negative regulatory element.
In general, the properties of ET-AG, PLZ-AG and GET-AG lines were similar in terms of the ability to activate transcription of the reporter gene in neurons n1±n7 and in motorneurons MN1-5. However, unlike the ET-AG lines and the GET-AG lines, the PLZ-AG lines never expressed high levels of the reporter gene in all of these neurons. Since six independent PLZ-AG lines were tested, it is unlikely that the low-level expression of the reporter gene was due to the chromosomal insertion site. We propose that PLZ-AG lines cannot achieve high level expression because of an incompatibility between the EcR-A regulatory regions and the Pelement promoter that controls transcription in all PLZ constructs. This possibility is based on the hypothesis that promoters and upstream regulatory elements have evolved to interact with each other (Li and Noll, 1994; Merli et al., 1996; Zhou et al., 1997; Yuh et al., 1998) . Thus, the enhancer-promoter interactions of vectors ET-AG and GET-AG that utilize the EcR-A promoter may retain a selected compatibility. As an example, high-level reporter gene expression was never observed in the n4 neurons of any PLZ transgenic construct (see Fig. 5 ). However, the observation that high-level reporter gene expression was detected in neurons n1, n3, n5, n6, and n7 of construct PLZ-BD was contrary to the enhancer-promoter matching hypothesis. To resolve these issues, it is essential to compare the ability of a single genomic fragment such as the 11.6 kb fragment encompassing interval AG, to drive the expression of a reporter gene such as LacZ, from a variety of different promoters without varying chromosomal location (Golic et al., 1997) .
At the outset of these investigations we predicted that a small number of regulatory elements would be responsible for up-regulating EcR-A in all of the Type II neurons. This prediction was based on the hypothesis that all Type II neurons were responding to a single developmental cue that would ultimately result in a de®ned set of transcription factors activating EcR-A through the interaction with discrete regulatory elements. Data presented here demonstrate that this hypothesis was incorrect and suggest instead that the Type II neurons are a heterogeneous group of neurons that utilize a variety of different transcriptional regulatory elements, and probably a variety of transcription factors, to up-regulate EcR-A in the appropriate temporal and spatial pattern. We are now in a position to attempt to identify the transcription factors that are acting through these regulatory elements.
Materials and methods
Stocks
Drosophila melanogaster were raised on standard media at 258C. A Canton-S strain was used for in situ hybridization experiments. A homozygous w 1118 strain was used as a genetic background for all P-element transformations. The UAS-mCD8-GFP stock was generously provided by Dr. L. Luo (Lee and Luo, 1999) .
Transgene construction 4.2.1. ET vectors
A 14 kb restriction fragment containing the complete ®rst exon of the EcR-A transcription unit and upstream sequences was isolated from l2.1 and cloned into the KpnI site of pBluescript II KS 1 (Stratagene) making plasmid pUSA. A 0.34 kb EcoRI-AluI restriction fragment containing the transcription start site of EcR-Ā anked by 130 bp of upstream sequence and 210 bp of downstream sequence was puri®ed from pUSA, blunt ended and cloned into a blunt-ended SacII digested C4PLZ vector. This 0.34 kb fragment was¯anked by an EcoRI site and a BamHI site in C4PLZ.
Vector ET was made by ligating this 0.34 kb EcR-A promoter as an EcoRI-BamHI restriction fragment into CaSpeR-AUG-bgal (Thummel et al., 1988) . The ability of this 0.34 kb fragment containing the EcR-A transcription start and 130 bp of upstream sequence to act as a functional promoter was tested by fusing the glass multimer reporter regulatory sequences (GMR) into the ET vector making ET-GMR. The GMR element acts as an enhancer and from a promoter, can drive expression of a reporter gene in all cells in and posterior to the morphogenetic furrow in the developing eye (Ellis et al., 1993; Hay et al., 1994) . The ET-GMR vector drives b-galactosidase expression as expected (data not shown) demonstrating that the 0.34 kb EcR-A fragment acts as a promoter.
Vector ET-GH was made by cloning the 6 kb EcoRI fragment of pUSA, interval GH, into EcoRI digested ET. Clones were identi®ed in which the 6 kb fragment inserted in the same orientation as found in genomic DNA with respect to the direction of transcription. Vector ET-AG was made by cloning interval AG as an 11.6 kb KpnI/ BglII fragment from pUSA into a modi®ed ET vector (ET2L2) in which a multiple cloning site had been placed upstream of the EcR-A promoter/transcription start site.
PLZ vectors
This series of vectors is based on the enhancer detector vector C4PLZ (Wharton and Crews, 1993) . Vector PLZ-AG containing interval A-G was made by ligating the 11.6 kb fragment from pUSA as a NotI-BglII fragment into C4PLZ. This fragment is identical to the genomic fragment in ET-AG. Vector PLZ-DG containing interval DG was made by ligating the 6.5 kb SalI-BglII fragment into NotI/BamHI cut C4PLZ. The SalI site was converted to a NotI site using NotI linkers. Vector PLZ-BD was made by ligating NotI linkers to the blunt-ended 3.6 kb XhoI fragment from pUSA, and cloning into NotI digested C4PLZ. Orientation of insertion identical to the genomic element with respect to the direc-tion of transcription was con®rmed by restriction enzyme analysis. Vector PLZ-AB containing interval AB was made by cloning the 4.3 kb EcoRI fragment of pUSA into EcoRI digested C4PLZ.
GET vectors
These constructs are enhancer tester constructs that drive the expression of the yeast GAL4 gene. To construct the basic GET vector, the EcR-A promoter from ET2L2 and the GAL4 open reading frame from pGaTB (Brand and Perrimon, 1993) were subcloned into the pCaSpeR4 Pelement vector (Thummel and Pirrotta, 1992) . This Pelement based vector contains a multiple cloning site upstream of the EcR-A transcription start site that controls transcription of the GAL4 open reading frame. GET-AG was generated by ligating the 11.6 kb regulatory region, interval AG, as a KpnI-NotI fragment into KpnI/NotI digested GET vector. During the subcloning process, a few hundred base pairs from interval A were deleted by an unknown mechanism. Therefore, GET-AG is not exactly equivalent to ET-AG or PLZ-AG. However, the data suggest that interval A does not contain any signi®cant regulatory elements that are detected by the assays described here. GET-BD was generated by ligating the 3.6 kb fragment as a NotI fragment into NotI digested GET. GET-CE was generated by ligating the 3.0 kb EcoRI fragment into EcoRI digested GET.
P-element mediated transformation
P-element mediated transformation was performed essentially as described (Rubin and Spradling, 1982) . The helper plasmid pUChspD2-3 served as a source of transposase (D. Rio, pers. commun.). All constructs were injected into w 1118 homozygous embryos. Multiple independent transformed lines of each construct were generated. Each insertion was mapped to a chromosome and homozygous stocks were established.
Only a single transformant of the PLZ-AG construct was isolated. To generate lines with different sites of insertion, the P-element of line PLZ-AG 1 was mobilized using standard genetic methods and P[ry 1 D2±3](99B) as a source of transposase (Robertson et al., 1988) . Progeny in which the element had transposed were selected based on changes in eye color.
The analysis of independent lines carrying the identical construct allowed us to distinguish features that were due to the site of insertion from those that were due to the genomic interval contained in the construct. In all cases, we have analyzed the expression of those lines that expressed the reporter gene at the highest levels reasoning that this would provide us with the most sensitive analysis. In general, the site of insertion played a major role in controlling the overall level of expression of the reporter gene. To account for minor inconsistencies that may be due to the site of insertion or that may re¯ect inherent differences between the three enhancer tester vectors used for these analyses, we have only mapped elements that mediated robust reporter gene expression in two or more independent lines.
Immunohistochemistry
Ventral nervous systems of staged animals were dissected and ®xed overnight in 4% paraformaldehyde (0.1 M sodium phosphate buffer, pH 7.3^0.1). After washing multiple times in phosphate buffered saline 1 0.3% Triton X-100 (PBS-TX) (Ashburner, 1990) , tissues were blocked for 30 min in an appropriate serum (5%), and incubated in primary antibody overnight at 48C.
EcR-A was detected immunohistochemically using monoclonal antibody (Mab) 15G1a which was raised against a fusion peptide containing the EcR-A speci®c amino-terminus of the ecdysone receptor . Mab 15G1a was used at a dilution of 1:50 or 1:100. Products of the reporter gene LacZ were detected with a polyclonal antibody generated in rabbit to b-galactosidase from E. coli (Cappel #55976). Prior to use, anti-bgalactosidase antibodies were diluted 1:100 and preabsorbed against dechorionated, ®xed, and devitellinized Drosophila embryos. The anti-b-galactosidase antibody was used at a ®nal dilution of 1:5000.
For immunoperoxidase stained preparations, tissues were incubated in biotinylated anti-rabbit IgG (1:200, Vector Laboratories), followed by incubation in an avidin-peroxidase complex (ABC kit, Vector Laboratories). Peroxidase was detected using diaminobenzidine as described (Robinow et al., 1993) except that the glucose oxidase method was used in lieu of the direct addition of hydrogen peroxide (Watson and Burrows, 1981) .
For double labeling and confocal analysis, prepared nervous systems were incubated sequentially in rabbit anti-b-galactosidase antibodies (1:5000), FITC-anti-rabbit IgG (1:200; Jackson ImmunoResearch), Mab 15G1a (1:50), biotinylated anti-mouse IgG (1:200, Vector Laboratories), and Texas Red-avidin (1:200, Vector Laboratories). After a ®nal wash in PBS-TX, tissues were rinsed in PBS, and mounted in Vectashield mounting medium (Vector Laboratories). Samples were viewed and analyzed on a BioRad MRC 1024 confocal microscope.
Indirect¯ight muscle preparations
Seventy-two hours old GET-AG; UAS-mCD8-GFP¯ies were dissected along the thoracic midline, ®xed overnight in 4% paraformaldehyde and processed using standard immunohistochemical techniques described above and by Lee and Luo (1999) . Immunoperoxidase stained preparations were viewed on a Leica DMRB compound microscope using Nomarski optics. A video camera (Sony DXC-970MD) was used to feed the live image to a monitor where the muscles and the CD8-immunoreactive axonal branching pattern were traced onto acetate sheets.
Whole-mount in situ hybridization
EcR-A speci®c single stranded digoxygenin-labeled RNA probe was transcribed from a derivative of pWT57 containing only exon A1 . Ventral nervous systems were removed 0±2 h after eclosion and processed as described previously (Robinow et al., 1997) . Samples were analyzed by light microscopy.
